Alpha 2.0
Login Register
» Articles » PMID: 3371391

Design of a New Multiple-unit Controlled-release Formulation of Metoprolol--metoprolol CR

Overview
Journal Eur J Clin Pharmacol
Specialty Pharmacology
Date 1988 Jan 1
PMID 3371391
Citations 18
Authors
A Sandberg
G Ragnarsson
U E Jonsson
J Sjogren
Affiliations
Soon will be listed here.
Abstract

A new controlled-release (CR) formulation of the beta 1-selective adrenoceptor antagonist metoprolol has been developed, aiming at an even 24-h pharmacological effect. In order to achieve this, using a once-daily dose, factors such as absorption characteristics, physicochemical properties, and technological aspects had to be considered. The new formulation, called metoprolol CR, is a disintegrating tablet consisting of several hundred coated pellets of metoprolol succinate, each pellet being its own CR delivery unit. In vitro testing and in vivo studies in healthy volunteers show that the new CR formulation gives continuous delivery of metoprolol throughout the day, resulting in smooth plasma concentration profiles, without peaks and troughs. The release of the drug is independent of pH and other physiological variables, such as food intake, which do not seem to alter the biopharmaceutical properties of the formulation.

Citing Articles

Redefinition to bilayer osmotic pump tablets as subterranean river system within mini-earth three-dimensional structure mechanism.

Maharjan A, Sun H, Cao Z, Li K, Liu J, Liu J Acta Pharm Sin B. 2022; 12(5):2568-2577.

PMID: 35646529 PMC: 9136608. DOI: 10.1016/j.apsb.2021.11.008.

Utilizing mixer torque rheometer in the prediction of optimal wet massing parameters for pellet formulation by extrusion/spheronization.

Ibrahim M, Zayed G, Alsharif F, Abdelhafez W Saudi Pharm J. 2019; 27(2):182-190.

PMID: 30766428 PMC: 6362277. DOI: 10.1016/j.jsps.2018.10.002.

Formulation of immediate release pellets containing famotidine solid dispersions.

Ibrahim M, El-Badry M Saudi Pharm J. 2014; 22(2):149-56.

PMID: 24648827 PMC: 3950527. DOI: 10.1016/j.jsps.2013.01.011.

Combination of Pectin and Eudargit RS and Eudragit RL in the Matrix of Pellets Prepared by Extrusion-Spheronization for Possible Colonic Delivery of 5-Amino Salicylic Acid.

Akhgari A, Abbaspour M, Moradkhanizadeh M Jundishapur J Nat Pharm Prod. 2014; 8(2):86-92.

PMID: 24624194 PMC: 3941906.

Metoprolol succinate extended release/hydrochlorothiazide combination tablets.

Hainer J, Sugg J Vasc Health Risk Manag. 2007; 3(3):279-88.

PMID: 17703635 PMC: 2293963.

References
1.
Melander A, Danielson K, SCHERSTEN B, Wahlin E . Enhancement of the bioavailability of propranolol and metoprolol by food. Clin Pharmacol Ther. 1977; 22(1):108-12. DOI: 10.1002/cpt1977221108. View
2.
Theeuwes F, SWANSON D, Guittard G, Ayer A, Khanna S . Osmotic delivery systems for the beta-adrenoceptor antagonists metoprolol and oxprenolol: design and evaluation of systems for once-daily administration. Br J Clin Pharmacol. 1985; 19 Suppl 2:69S-76S. PMC: 1463768. DOI: 10.1111/j.1365-2125.1985.tb02745.x. View
3.
Karim A, Burns T, Wearley L, Streicher J, Palmer M . Food-induced changes in theophylline absorption from controlled-release formulations. Part I. Substantial increased and decreased absorption with Uniphyl tablets and Theo-Dur Sprinkle. Clin Pharmacol Ther. 1985; 38(1):77-83. DOI: 10.1038/clpt.1985.138. View
4.
Johnsson G, Regardh C, SOLVELL L . Combined pharmacokinetic and pharmacodynammc studies in man of the adrenergic beta1-receptor antagonist metoprolol. Acta Pharmacol Toxicol (Copenh). 1975; 36(Suppl 5):31-44. DOI: 10.1111/j.1600-0773.1975.tb03320.x. View
5.
Godbillon J, Evard D, Vidon N, Duval M, SCHOELLER J, BERNIER J . Investigation of drug absorption from the gastrointestinal tract of man. III. Metoprolol in the colon. Br J Clin Pharmacol. 1985; 19 Suppl 2:113S-118S. PMC: 1463759. DOI: 10.1111/j.1365-2125.1985.tb02751.x. View